BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32632818)

  • 1. GTPase Activity of MxB Contributes to Its Nuclear Location, Interaction with Nucleoporins and Anti-HIV-1 Activity.
    Xie L; Ju Z; Zhong C; Wu Y; Zan Y; Hou W; Feng Y
    Virol Sin; 2021 Feb; 36(1):85-94. PubMed ID: 32632818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid.
    Xu F; Zhao F; Zhao X; Zhang D; Liu X; Hu S; Mei S; Fan Z; Huang Y; Sun H; Wei L; Wu C; Li Q; Wang J; Cen S; Liang C; Guo F
    J Biol Chem; 2020 May; 295(19):6447-6456. PubMed ID: 32217692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restriction of HIV-1 Requires the N-Terminal Region of MxB as a Capsid-Binding Motif but Not as a Nuclear Localization Signal.
    Schulte B; Buffone C; Opp S; Di Nunzio F; De Souza Aranha Vieira DA; Brandariz-Nuñez A; Diaz-Griffero F
    J Virol; 2015 Aug; 89(16):8599-610. PubMed ID: 26063425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus specificity and nucleoporin requirements for MX2 activity are affected by GTPase function and capsid-CypA interactions.
    Layish B; Goli R; Flick H; Huang SW; Zhang RZ; Kvaratskhelia M; Kane M
    PLoS Pathog; 2024 Mar; 20(3):e1011830. PubMed ID: 38512975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of MxB oligomerization to HIV-1 capsid binding and restriction.
    Buffone C; Schulte B; Opp S; Diaz-Griffero F
    J Virol; 2015 Mar; 89(6):3285-94. PubMed ID: 25568212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GTPase Domain of MX2 Interacts with the HIV-1 Capsid, Enabling Its Short Isoform to Moderate Antiviral Restriction.
    Betancor G; Dicks MDJ; Jimenez-Guardeño JM; Ali NH; Apolonia L; Malim MH
    Cell Rep; 2019 Nov; 29(7):1923-1933.e3. PubMed ID: 31722207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MxB impedes the NUP358-mediated HIV-1 pre-integration complex nuclear import and viral replication cooperatively with CPSF6.
    Xie L; Chen L; Zhong C; Yu T; Ju Z; Wang M; Xiong H; Zeng Y; Wang J; Hu H; Hou W; Feng Y
    Retrovirology; 2020 Jun; 17(1):16. PubMed ID: 32600399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host and viral determinants for MxB restriction of HIV-1 infection.
    Matreyek KA; Wang W; Serrao E; Singh PK; Levin HL; Engelman A
    Retrovirology; 2014 Oct; 11():90. PubMed ID: 25348155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human MX2/MxB: a Potent Interferon-Induced Postentry Inhibitor of Herpesviruses and HIV-1.
    Staeheli P; Haller O
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30258007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
    Ji S; Na L; Ren H; Wang Y; Wang X
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human MxB Protein Is a Pan-herpesvirus Restriction Factor.
    Schilling M; Bulli L; Weigang S; Graf L; Naumann S; Patzina C; Wagner V; Bauersfeld L; Goujon C; Hengel H; Halenius A; Ruzsics Z; Schaller T; Kochs G
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction.
    Dicks MDJ; Betancor G; Jimenez-Guardeño JM; Pessel-Vivares L; Apolonia L; Goujon C; Malim MH
    PLoS Pathog; 2018 Nov; 14(11):e1007408. PubMed ID: 30496303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligomerization Requirements for MX2-Mediated Suppression of HIV-1 Infection.
    Dicks MD; Goujon C; Pollpeter D; Betancor G; Apolonia L; Bergeron JR; Malim MH
    J Virol; 2016 Jan; 90(1):22-32. PubMed ID: 26446602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insight into HIV-1 restriction by MxB.
    Fribourgh JL; Nguyen HC; Matreyek KA; Alvarez FJD; Summers BJ; Dewdney TG; Aiken C; Zhang P; Engelman A; Xiong Y
    Cell Host Microbe; 2014 Nov; 16(5):627-638. PubMed ID: 25312384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1.
    Fricke T; White TE; Schulte B; de Souza Aranha Vieira DA; Dharan A; Campbell EM; Brandariz-Nuñez A; Diaz-Griffero F
    Retrovirology; 2014 Aug; 11():68. PubMed ID: 25123063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MXB inhibits murine cytomegalovirus.
    Jaguva Vasudevan AA; Bähr A; Grothmann R; Singer A; Häussinger D; Zimmermann A; Münk C
    Virology; 2018 Sep; 522():158-167. PubMed ID: 30032029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MxB Restricts HIV-1 by Targeting the Tri-hexamer Interface of the Viral Capsid.
    Smaga SS; Xu C; Summers BJ; Digianantonio KM; Perilla JR; Xiong Y
    Structure; 2019 Aug; 27(8):1234-1245.e5. PubMed ID: 31155311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interferon-inducible GTPase MxB promotes capsid disassembly and genome release of herpesviruses.
    Serrero MC; Girault V; Weigang S; Greco TM; Ramos-Nascimento A; Anderson F; Piras A; Hickford Martinez A; Hertzog J; Binz A; Pohlmann A; Prank U; Rehwinkel J; Bauerfeind R; Cristea IM; Pichlmair A; Kochs G; Sodeik B
    Elife; 2022 Apr; 11():. PubMed ID: 35475759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MxB is an interferon-induced restriction factor of human herpesviruses.
    Crameri M; Bauer M; Caduff N; Walker R; Steiner F; Franzoso FD; Gujer C; Boucke K; Kucera T; Zbinden A; Münz C; Fraefel C; Greber UF; Pavlovic J
    Nat Commun; 2018 May; 9(1):1980. PubMed ID: 29773792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MxB Is Not Responsible for the Blocking of HIV-1 Infection Observed in Alpha Interferon-Treated Cells.
    Opp S; Vieira DA; Schulte B; Chanda SK; Diaz-Griffero F
    J Virol; 2015 Dec; 90(6):3056-64. PubMed ID: 26719253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.